Capromorelin vs L-692,429

Head-to-head comparison of Capromorelin (Capromorelin hydrochloride) and L-692,429 (L-692,429) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyCapromorelinL-692,429
CategoryGrowth HormoneGrowth Hormone
Full NameCapromorelin hydrochlorideL-692,429
Molecular WeightN/AN/A
Half-Lifeabout 2-3 hoursunknown / study-dependent
Amino AcidsN/AN/A
Typical Dose0.25-2 mg/kg/day0.03-0.1 mg/kg
RouteOralOral
Purity≥98%≥98%
Studies Count5530
Research StatusClinicalPre-clinical

Capromorelin Benefits

  • GH secretagogue activity
  • appetite stimulation
  • oral administration
  • translational animal model utility

L-692,429 Benefits

  • potent GHSR agonism
  • oral bioactivity in models
  • validates ghrelin pathway
  • useful research probe

Capromorelin Dosing

0.25-2 mg/kg orally in studies|once-daily or protocol-specific dosing|monitor appetite and body weight

L-692,429 Dosing

0.03-0.1 mg/kg in early studies|single oral or short-course research dosing|serial GH sampling recommended

Capromorelin Side Effects

  • increased appetite
  • vomiting or nausea
  • lethargy

L-692,429 Side Effects

  • increased appetite
  • glucose intolerance
  • transient prolactin changes

Research Overview

Capromorelin

Research consistently shows capromorelin activates the ghrelin receptor pathway and increases food intake. Human development has been less prominent than veterinary use, but the compound remains a relevant GH secretagogue prototype.

L-692,429

L-692,429 was important in early GH secretagogue research because it showed that nonpeptide molecules could trigger robust GH release. It remains a classic tool compound for studying receptor-mediated GH pulsatility and appetite signaling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Capromorelin stacks with:

Nutritional supportResistance training

L-692,429 stacks with:

Receptor assaysEndocrine studies
ghrelin-receptor-agonistappetite-stimulantgh-secretagoguetool-compoundghrelin-pathway